Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update
by Sarita Garza · The Markets DailyGlobal X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a significant drop in short interest in the month of December. As of December 31st, there was short interest totaling 7,741 shares, a drop of 57.7% from the December 15th total of 18,284 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 23,041 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 23,041 shares, the short-interest ratio is currently 0.3 days. Approximately 0.6% of the shares of the stock are short sold.
Global X HealthTech ETF Stock Performance
HEAL traded down $0.39 during midday trading on Friday, hitting $30.58. The stock had a trading volume of 6,256 shares, compared to its average volume of 13,451. Global X HealthTech ETF has a 1 year low of $24.48 and a 1 year high of $35.73. The business has a fifty day moving average of $30.44 and a 200 day moving average of $31.33. The company has a market cap of $42.20 million, a P/E ratio of 42.80 and a beta of 1.13.
Global X HealthTech ETF Dividend Announcement
The company also recently announced a dividend, which was paid on Wednesday, January 7th. Shareholders of record on Tuesday, December 30th were issued a dividend of $0.0718 per share. The ex-dividend date was Tuesday, December 30th.
Institutional Trading of Global X HealthTech ETF
Hedge funds have recently made changes to their positions in the stock. Flow Traders U.S. LLC bought a new position in Global X HealthTech ETF in the 3rd quarter valued at approximately $368,000. Citadel Advisors LLC bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter worth $216,000. Raymond James Financial Inc. purchased a new position in shares of Global X HealthTech ETF in the third quarter worth $274,000. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $11,239,000. Finally, Glenmede Investment Management LP bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $31,000.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.